Home
Quell Therapeutics Ltd.

Quell Therapeutics Ltd. Market Share Analysis for August 2026

Health > Biotechnology and Pharmaceuticals

Domainquell-tx.com

Year Founded2019

Employees51 - 200

Annual Revenue$2M - $5M

Quell Therapeutics Ltd.

Quell Therapeutics Ltd. (including company regionals)

quell-tx.com

See more website traffic and engagement information

Quell Therapeutics Ltd. Revenue up to August 2026 is 2M - 5M

revenue generated by Quell Therapeutics Ltd. top domains

Quell Therapeutics Ltd. top domains revenue over 3 years

Revenue for Quell Therapeutics Ltd. top domains

quell-tx.com2M - 5M

See more with Sales Intelligence

Total visits to Quell Therapeutics Ltd.'s top domains

Understand Quell Therapeutics Ltd. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

quell-tx.com8.7K

See more with Sales Intelligence

Avg. visit duration in Quell Therapeutics Ltd.'s top domains

Analyze Quell Therapeutics Ltd. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

quell-tx.com00:00:57

See more with Sales Intelligence

Avg. pageviews on Quell Therapeutics Ltd.'s top domains

See how Quell Therapeutics Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

quell-tx.com2.14

See more with Sales Intelligence

Quell Therapeutics Ltd. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Quell Therapeutics Ltd.

These are the website technologies, by industry, used by Quell Therapeutics Ltd. top domains

Email Services (4)

G Suite

Widget (4)

Twemoji

Advertising (2)

DoubleClick

Payment & Currencies (2)

Euro

More Technologies

9

See all

News & Signals from Quell Therapeutics Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsQuellTX Ltd attends event ACR Convergence 2025.Quell Therapeutics to unveil promising data for QEL-005, a novel CAR-Treg cell therapy for Complex Autoimmune diseases, at ACR Convergence 2025.

NewsQuellTX Ltd attended event The Liver Meeting on Oct 22nd '25.London, UK - October 22, 2024 - Quell Therapeutics Ltd ("Quell"), a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announces upcoming oral and poster presentations at the 2024 European Society of Gene and Cell Therapy (ESGCT) 31st Annual Congress, held in Rome, Italy (October 22-25, 2024) and at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting, held in San Diego, CA (November 15-19).